We also detected elevated phospho-S6 (protein S6; p-S6), a downstream target of the PI3K/AKT/mTOR pathway, in the AML cell lines compared to the B-ALL cell lines (p = 0.0303). This evidence concerns the gene MTOR and acute lymphoblastic leukemia.